|
1
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar
|
|
2
|
Matsuda A, Matsuda T, Shibata A, et al:
Cancer incidence and incidence rates in Japan in 2008: a study of
25 population-based cancer registries for the Monitoring of Cancer
Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 44:388–396.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Friedl P and Wolf K: Tumour-cell invasion
and migration: diversity and escape mechanisms. Nat Rev Cancer.
3:362–374. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar
|
|
5
|
Rybinski B, Franco-Barraza J and Cukierman
E: The wound healing, chronic fibrosis and cancer progression
triad. Physiol Genomics. 46:223–244. 2014. View Article : Google Scholar
|
|
6
|
Savagner P, Valles AM, Jouanneau J, Yamada
KM and Thiery JP: Alternative splicing in fibroblast growth factor
receptor 2 is associated with induced epithelial-mesenchymal
transition in rat bladder carcinoma cells. Mol Biol Cell.
5:851–862. 1994. View Article : Google Scholar
|
|
7
|
Warzecha CC, Sato TK, Nabet B, Hogenesch
JB and Carstens RP: ESRP1 and ESRP2 are epithelial
cell-type-specific regulators of FGFR2 splicing. Mol Cell.
33:591–601. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shapiro IM, Cheng AW, Flytzanis NC, et al:
An EMT-driven alternative splicing program occurs in human breast
cancer and modulates cellular phenotype. PLoS Genet.
7:e10022182011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Barzik M, Kotova TI, Higgs HN, et al:
Ena/VASP proteins enhance actin polymerization in the presence of
barbed end capping proteins. J Biol Chem. 280:28653–28662. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bear JE, Svitkina TM, Krause M, et al:
Antagonism between Ena/VASP proteins and actin filament capping
regulates fibroblast motility. Cell. 109:509–521. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gertler F and Condeelis J: Metastasis:
tumor cells becoming MENAcing. Trends Cell Biol. 21:81–90. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Di Modugno F, DeMonte L, Balsamo M, et al:
Molecular cloning of hMena (ENAH) and its splice variant
hMena+11a: epidermal growth factor increases their
expression and stimulates hMena+11a phosphorylation in
breast cancer cell lines. Cancer Res. 67:2657–2665. 2007.PubMed/NCBI
|
|
13
|
Urbanelli L, Massini C, Emiliani C and
Orlacchio A, Bernardi G and Orlacchio A: Characterization of human
Enah gene. Biochim Biophys Acta. 1759:99–107. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Itakura M, Terashima Y, Shingyoji M, et
al: High CC chemokine receptor 7 expression improves postoperative
prognosis of lung adenocarcinoma patients. Br J Cancer.
109:1100–1108. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Monney L, Sabatos CA, Gaglia JL, et al:
Th1-specific cell surface protein Tim-3 regulates macrophage
activation and severity of an autoimmune disease. Nature.
415:536–541. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ellis I and Simpson J: Grading. WHO
Classification of Tumours of the Breast. Lakhani S, Ellis I and
Schnitt S: IARC Press; Lyon: pp. 19–23. 2012
|
|
17
|
Ellis I, Collins L and Ichihara S:
Invasive carcinoma of no special type. WHO Classification of
Tumours of the Breast. Lakhani S, Ellis I and Schnitt S: IARC
Press; Lyon: pp. 34–38. 2012
|
|
18
|
Goswami S, Philippar U, Sun D, et al:
Identification of invasion specific splice variants of the
cytoskeletal protein Mena present in mammary tumor cells during
invasion in vivo. Clin Exp Metastasis. 26:153–159. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Philippar U, Roussos ET, Oser M, et al: A
Mena invasion isoform potentiates EGF-induced carcinoma cell
invasion and metastasis. Dev Cell. 15:813–828. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pino MS, Balsamo M, Di Modugno F, et al:
Human Mena+11a isoform serves as a marker of epithelial
phenotype and sensitivity to epidermal growth factor receptor
inhibition in human pancreatic cancer cell lines. Clin Cancer Res.
14:4943–4950. 2008.PubMed/NCBI
|
|
21
|
Agarwal S, Gertler FB, Balsamo M, et al:
Quantitative assessment of invasive mena isoforms (Menacalc) as an
independent prognostic marker in breast cancer. Breast Cancer Res.
14:R1242012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wapnir IL, Dignam JJ, Fisher B, et al:
Long-term outcomes of invasive ipsilateral breast tumor recurrences
after lumpectomy in NSABP B-17 and B-24 randomized clinical trials
for DCIS. J Natl Cancer Inst. 103:478–488. 2011. View Article : Google Scholar
|
|
23
|
Roussos ET, Balsamo M, Alford SK, et al:
Mena invasive (MenaINV) promotes multicellular streaming
motility and transendothelial migration in a mouse model of breast
cancer. J Cell Sci. 124:2120–2131. 2011.PubMed/NCBI
|
|
24
|
Roussos ET, Goswami S, Balsamo M, et al:
Mena invasive (MenaINV) and Mena11a isoforms
play distinct roles in breast cancer cell cohesion and association
with TMEM. Clin Exp Metastasis. 28:515–527. 2011.PubMed/NCBI
|
|
25
|
Warzecha CC and Carstens RP: Complex
changes in alternative pre-mRNA splicing play a central role in the
epithelial-to-mesenchymal transition (EMT). Semin Cancer Biol.
22:417–427. 2012. View Article : Google Scholar : PubMed/NCBI
|
